The management and outcome of chronic graft-versus-host disease

British Journal of Haematology

Volumn 138, Issue 2, 2007, Pages 131-145

  Fraser, Christopher J ^a   Scott Baker, K ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Allogeneic haematopoietic cell transplantation; Chronic graft versus host disease; Prognosis; Treatment

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PRAVASTATIN; PREDNISOLONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY;

ALLOGENEIC STEM CELL TRANSPLANTATION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CORTICOSTEROID THERAPY; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; MONOTHERAPY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT DURATION;

ADRENAL CORTEX HORMONES; CALCINEURIN; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION CONTROL; PATIENT CARE TEAM; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 34250812705     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06652.x     Document Type: Review

References (133)

1. Akpek, G., Zahurak, M.L., Piantadosi, S., Margolis, J., Doherty, J., Davidson, R. Vogelsang, G.B. (2001a) Development of a prognostic model for grading chronic graft-versus-host disease. Blood, 97, 1219 1226.
2. Akpek, G., Lee, S.M., Anders, V. Vogelsang, G.B. (2001b) A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease. Biology Blood Marrow Transplantation, 7, 495 502.
3. Alcindor, T., Gorgun, G., Miller, K.B., Roberts, T.F., Sprague, K., Schenkein, D.P. Foss, F.M. (2001) Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood, 98, 1622 1625.
4. Arat, M., Ilhan, O., Iayan, E.A., Celebi, H., Koc, H. Akan, H. (2001) Treatment of extensive chronic sclerodermatous graft-versus-host disease with high-dose immunosuppressive therapy and CD34+ autologous stem cell rescue. Blood, 98, 892 893.
5. Arat, M., Idilman, R., Soydan, E.A., Soykan, I., Erden, E., Karayalcin, S. Akan, H. (2005) Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver. Clinical Transplantation, 19, 798 803.
6. Arora, M., Wagner, J.E., Davies, S.M., Blazar, B.R., Defor, T., Enright, H., Miller, W.J. Weisdorf, D.F. (2001) Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease. Biology Blood Marrow Transplantation, 7, 265 273.
7. Arora, M., Burns, L.J., Davies, S.M., Macmillan, M.L., Defor, T.E., Miller, W.J. Weisdorf, D.J. (2003) Chronic graft-versus-host disease: a prospective cohort study. Biology Blood Marrow Transplantation, 9, 38 45.
8. Aversa, F., Terenzi, A., Tabilio, A., Falzetti, F., Carotti, A., Ballanti, S., Felicini, R., Falcinelli, F., Velardi, A., Ruggeri, L., Aloisi, T., Saab, J.P., Santucci, A., Perruccio, K., Martelli, M.P., Mecucci, C., Reisner, Y. Martelli, M.F. (2005) Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. Journal of Clinical Oncology, 23, 3447 3454.
9. Bacigalupo, A., Lamparelli, T., Bruzzi, P., Guidi, S., Alessandrino, P.E., Bartolomeo di P., Bruno, R., Barbanti, B., Sacchi, M., Van, N., Lint, M.T. Bosi, A. (2001) Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood, 98, 2942 2947.
10. Bacigalupo, A., Lamparelli, T., Barisione, G., Bruzzi, P., Guidi, S., Alessandrino, P.E., di Bartolomeo, P., Oneto, R., Bruno, B., Sacchi, N., van Lint, M.T. Bosi, A. (2006) Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biology Blood Marrow Transplantation, 12, 560 565.
11. Baker, K.S., Gurney, J.G., Ness, K.K., Bhatia, R., Forman, S.J., Francisco, L., McGlave, P.B., Robison, L.L., Snyder, D.S., Weisdorf, D.J. Bhatia, S. (2004) Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood, 104, 1898 1906.
12. Ballen, K.K., Spitzer, T.R., Yeap, B.Y., McAfee, S., Dey, B.R., Attar, E., Haspel, R., Kao, G., Liney, D., Alyea, E., Lee, S., Cutler, C., Ho, V., Soiffer, R. Antin, J.H. (2007) Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biology Blood Marrow Transplantation, 13, 82 89.
13. Boeckh, M., Kim, H.W., Flowers, M.E., Meyers, J.D. Bowden, R.A. (2006) Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation - a randomized double-blind placebo-controlled study. Blood, 107, 1800 1805.
14. Browning, B., Thormann, K., Seshadri, R., Duerst, R., Kletzel, M. Jacobsohn, D.A. (2006) Weight loss and reduced body mass index: a critical issue in children with multiorgan chronic graft-versus-host disease. Bone Marrow Transplantation, 37, 527 533.
15. Busca, A., Saroglia, E.M., Lanino, E., Manfredini, L., Uderzo, C., Nicolini, B., Messina, C., Rabusin, M. Miniero, R. (2000) Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation. Bone Marrow Transplantation, 25, 1067 1071.
16. Busca, A., Locatelli, F., Marmont, F., Audisio, E. Falda, M. (2003) Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease. Haematologica, 88, 837 839.
17. Busca, A., Locatelli, F., Marmont, F., Ceretto, C. Falda, M. (2007) Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. American Journal of Hematology, 82, 45 52.
18. Canninga-van Dijk, M.R., der Straaten, H.M., Fijnheer, R., Sanders, C.J., den Tweel, J.G. Verdonck, L.F. (2004) Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease. Blood, 104, 2603 2606.
19. Carnevale-Schianca, F., Martin, P., Sullivan, K., Flowers, M., Gooley, T., Anasetti, C., Deeg, J., Furlong, T., McSweeney, P., Storb, R. Nash, R.A. (2000) Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease. Biology Blood Marrow Transplantation, 6, 613 620.
20. CDC (2000) Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recommendation and Reports, 49, 1 125, CE121 127.
21. Chakrabarti, S., Mackinnon, S., Chopra, R., Kottaridis, P.D., Peggs, K., O'Gorman, P., Chakraverty, R., Marshall, T., Osman, H., Mahendra, P., Craddock, C., Waldmann, H., Hale, G., Fegan, C.D., Yong, K., Goldstone, A.H., Linch, D.C. Milligan, D.W. (2002) High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood, 99, 4357 4363.
22. Chakrabarti, S., MacDonald, D., Hale, G., Holder, K., Turner, V., Czarnecka, H., Thompson, J., Fegan, C., Waldmann, H. Milligan, D.W. (2003) T-cell depletion with Campath-1H 'in the bag' for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival. Britsh Journal of Haematology, 121, 109 118.
23. Champlin, R.E., Passweg, J.R., Zhang, M.J., Rowlings, P.A., Pelz, C.J., Atkinson, K.A., Barrett, A.J., Cahn, J.Y., Drobyski, W.R., Gale, R.P., Goldman, J.M., Gratwohl, A., Gordon-Smith, E.C., Henslee-Downey, P.J., Herzig, R.H., Klein, J.P., Marmont, A.M., O'Reilly, R.J., Ringden, O., Slavin, S., Sobocinski, K.A., Speck, B., Weiner, R.S. Horowitz, M.M. (2000) T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood, 95, 3996 4003.
24. Chao, N.J., Parker, P.M., Niland, J.C., Wong, R.M., Dagis, A., Long, G.D., Nademanee, A.P., Negrin, R.S., Snyder, D.S., Hu, W.W., Gould, K.A., Tierney, D.K., Zwingenberger, K., Forman, S.J. Blume, K.G. (1996) Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease. Biology Blood Marrow Transplantation, 2, 86 92.
25. Chao, N.J., Snyder, D.S., Jain, M., Wong, R.M., Niland, J.C., Negrin, R.S., Long, G.D., Hu, W.W., Stockerl-Goldstein, K.E., Johnston, L.J., Amylon, M.D., Tierney, D.K., O'Donnell, M.R., Nademanee, A.P., Parker, P., Stein, A., Molina, A., Fung, H., Kashyap, A., Kohler, S., Spielberger, R., Krishnan, A., Rodriguez, R., Forman, S.J. Bluzme, K.G. (2000) Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial. Biology Blood Marrow Transplantation, 6, 254 261.
26. Chiodi, S., Spinelli, S., Ravera, G., Petti, A.R., Van Lint, M.T., Lamparelli, T., Gualandi, F., Occhini, D., Mordini, N., Berisso, G., Bregante, S., Frassoni, F. Bacigalupo, A. (2000) Quality of life in 244 recipients of allogeneic bone marrow transplantation. British Journal of Haematology, 110, 614 619.
27. Clark, F.J., Gregg, R., Piper, K., Dunnion, D., Freeman, L., Griffiths, M., Begum, G., Mahendra, P., Craddock, C., Moss, P. Chakraverty, R. (2004) Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. Blood, 103, 2410 2416.
28. Couriel, D.R., Saliba, R.M., Giralt, S., Khouri, I., Andersson, B., de Lima, M., Hosing, C., Anderlini, P., Donato, M., Cleary, K., Gajewski, J., Neumann, J., Ippoliti, C., Rondon, G., Cohen, A. Champlin, R. (2004) Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation. Biology Blood Marrow Transplantation, 10, 178 185.
29. Couriel, D.R., Saliba, R., Escalon, M.P., Hsu, Y., Ghosh, S., Ippoliti, C., Hicks, K., Donato, M., Giralt, S., Khouri, I.F., Hosing, C., de Lima, M.J., Andersson, B., Neumann, J. Champlin, R. (2005) Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. British Journal of Haematology, 130, 409 417.
30. Couriel, D., Carpenter, P.A., Cutler, C., Bolanos-Meade, J., Treister, N.S., Gea-Banacloche, J., Shaughnessy, P., Hymes, S., Kim, S., Wayne, A.S., Chien, J.W., Neumann, J., Mitchell, S., Syrjala, K., Moravec, C.K., Abramovitz, L., Liebermann, J., Berger, A., Gerber, L., Schubert, M., Filipovich, A.H., Weisdorf, D., Schubert, M.M., Shulman, H., Schultz, K., Mittelman, B., Pavletic, S., Vogelsang, G.B., Martin, P.J., Lee, S.J. Flowers, M.E. (2006a) Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biology Blood Marrow Transplantation, 12, 375 396.
31. Couriel, D.R., Hosing, C., Saliba, R., Shpall, E.J., Anderlini, P., Rhodes, B., Smith, V., Khouri, I., Giralt, S., de Lima, M., Hsu, Y., Ghosh, S., Neumann, J., Andersson, B., Qazilbash, M., Hymes, S., Kim, S., Champlin, R. Donato, M. (2006b) Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood, 107, 3074 3080.
32. Curtis, R.E., Metayer, C., Rizzo, J.D., Socie, G., Sobocinski, K.A., Flowers, M.E., Travis, W.D., Travis, L.B., Horowitz, M.M. Deeg, H.J. (2005) Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood, 105, 3802 3811.
33. Cutler, C., Giri, S., Jeyapalan, S., Paniagua, D., Viswanathan, A. Antin, J.H. (2001) Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. Journal of Clinical Oncology, 19, 3685 3691.
34. Cutler, C., Kim, H.T., Hochberg, E., Ho, V., Alyea, E., Lee, S.J., Fisher, D.C., Miklos, D., Levin, J., Sonis, S., Soiffer, R.J. Antin, J.H. (2004) Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation. Biology Blood Marrow Transplantation, 10, 328 336.
35. Cutler, C., Miklos, D., Kim, H.T., Treister, N., Woo, S.B., Bienfang, D., Klickstein, L.B., Levin, J., Miller, K., Reynolds, C., Macdonell, R., Pasek, M., Lee, S.J., Ho, V., Soiffer, R., Antin, J.H., Ritz, J. Alyea, E. (2006) Rituximab for steroid-refractory chronic graft-versus-host disease. Blood, 108, 756 762.
36. Deeg, H.J., Lin, D., Leisenring, W., Boeckh, M., Anasetti, C., Appelbaum, F.R., Chauncey, T.R., Doney, K., Flowers, M., Martin, P., Nash, R., Schoch, G., Sullivan, K.M., Witherspoon, R.P. Storb, R. (1997) Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial. Blood, 89, 3880 3887.
37. Deeg, H.J., Leisenring, W., Storb, R., Nims, J., Flowers, M.E., Witherspoon, R.P., Sanders, J. Sullivan, K.M. (1998) Long-term outcome after marrow transplantation for severe aplastic anemia. Blood, 91, 3637 3645.
38. Dudek, A.Z., Mahaseth, H., DeFor, T.E. Weisdorf, D.J. (2003) Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biology Blood Marrow Transplantation, 9, 657 666.
39. Filipovich, A.H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J.R., Lee, S.J., Martin, P., Chien, J., Przepiorka, D., Couriel, D., Cowen, E.W., Dinndorf, P., Farrell, A., Hartzman, R., Henslee-Downey, J., Jacobsohn, D., McDonald, G., Mittleman, B., Rizzo, J.D., Robinson, M., Schubert, M., Schultz, K., Shulman, H., Turner, M., Vogelsang, G. Flowers, M.E. (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biology Blood Marrow Transplantation, 11, 945 956.
40. Flowers, M.E., Parker, P.M., Johnston, L.J., Matos, A.V., Storer, B., Bensinger, W.I., Storb, R., Appelbaum, F.R., Forman, S.J., Blume, K.G. Martin, P.J. (2002) Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood, 100, 415 419.
41. Forsyth, C.J., Cremer, P.D., Torzillo, P., Iland, H.J. Young, G.A. (1996) Thalidomide responsive chronic pulmonary GVHD. Bone Marrow Transplantation, 17, 291 293.
42. Foss, F.M., Gorgun, G. Miller, K.B. (2002) Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transplantation, 29, 719 725.
43. Foss, F.M., DiVenuti, G.M., Chin, K., Sprague, K., Grodman, H., Klein, A., Chan, G., Stiffler, K. Miller, K.B. (2005) Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplantation, 35, 1187 1193.
44. Fraser, C.J., Bhatia, S., Ness, K., Carter, A., Francisco, L., Arora, M., Parker, P., Forman, S., Weisdorf, D., Gurney, J.G. Baker, K.S. (2006) Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood, 108, 2867 2873.
45. Fried, R.H., Murakami, C.S., Fisher, L.D., Willson, R.A., Sullivan, K.M. McDonald, G.B. (1992) Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver. Annuals International of Medicine, 116, 624 629.
46. Fullmer, J.J., Fan, L.L., Dishop, M.K., Rodgers, C. Krance, R. (2005) Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-alpha blockade. Pediatrics, 116, 767 770.
47. Garban, F., Drillat, P., Makowski, C., Jacob, M.C., Richard, M.J., Favrot, M., Sotto, J.J., Bensa, J.C. Cahn, J.Y. (2005) Extracorporeal chemophototherapy for the treatment of graft-versus-host disease: hematologic consequences of short-term, intensive courses. Haematologica, 90, 1096 1101.
48. Giaccone, L., Martin, P., Carpenter, P., Moravec, C., Hooper, H., Funke, V.A., Storb, R. Flowers, M.E. (2005) Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease. Bone Marrow Transplantation, 36, 337 341.
49. Gilman, A.L., Chan, K.W., Mogul, A., Morris, C., Goldman, F.D., Boyer, M., Cirenza, E., Mazumder, A., Gehan, E., Cahill, R., Frankel, S. Schultz, K. (2000) Hydroxychloroquine for the treatment of chronic graft-versus-host disease. Biology Blood Marrow Transplantation, 6, 327 334.
50. Goerner, M., Gooley, T., Flowers, M.E., Sullivan, K.M., Kiem, H.P., Sanders, J.E., Martin, P.J. Storb, R. (2002) Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biology Blood Marrow Transplantation, 8, 47 56.
51. Goldberg, J.D., Jacobsohn, D.A., Margolis, J., Chen, A.R., Anders, V., Phelps, M. Vogelsang, G.B. (2003) Pentostatin for the treatment of chronic graft-versus-host disease in children. Journal of Pediatric Hematology Oncology, 25, 584 588.
52. Gratwohl, A., Brand, R., Apperley, J., Biezen Av, A., Bandini, G., Devergie, A., Schattenberg, A., Frassoni, F., Guglielmi, C., Iacobelli, S., Michallet, M., Kolb, H.J., Ruutu, T. Niederwieser, D. (2002) Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood, 100, 3877 3886.
53. Hale, G., Zhang, M.J., Bunjes, D., Prentice, H.G., Spence, D., Horowitz, M.M., Barrett, A.J. Waldmann, H. (1998) Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. Blood, 92, 4581 4590.
54. Hess, A.D., Horwitz, L., Beschorner, W.E. Santos, G.W. (1985) Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity. Journal of Experimental Medicine, 161, 718 730.
55. Holland, H.K., Wingard, J.R., Beschorner, W.E., Saral, R. Santos, G.W. (1988) Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-vs-host disease and low serum IgG. Blood, 72, 621 627.
56. Hori, A., Kanda, Y., Goyama, S., Onishi, Y., Komeno, Y., Mitani, K., Kishi, Y., Ogawa, S., Imataki, O., Chiba, S., Kojima, R., Hamaki, T., Sakiyama, M., Kami, M., Makimoto, A., Tanosaki, R., Takaue, Y. Hirai, H. (2005) A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease. Transplantation, 79, 372 374.
57. Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., Truitt, R.L., Zwaan, F.E. Bortin, M.M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555 562.
58. Ilhan, O., Arat, M., Arslan, O., Ayyildiz, E., Sanli, H., Beksac, M., Ozcan, M., Gurman, G. Akan, H. (2004) Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease. Transfusion and Aphereis Science, 30, 185 187.
59. Jacobsohn, D.A., Montross, S., Anders, V. Vogelsang, G.B. (2001) Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease. Bone Marrow Transplantation, 28, 1047 1051.
60. Johnston, L.J., Brown, J., Shizuru, J.A., Stockerl-Goldstein, K.E., Stuart, M.J., Blume, K.G., Negrin, R.S. Chao, N.J. (2005) Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biology Blood Marrow Transplantation, 11, 47 55.
61. Kanamaru, A., Takemoto, Y., Kakishita, E., Dohy, H., Kodera, Y., Moriyama, Y., Shibata, A., Kasai, M., Katoh, S., Saitoh, H., Matsuda, T., Hattori, M., Okamoto, S., Asano, S., Horiuchi, A., Harada, M., Hiraoka, A. Masaoka, T. (1995) FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. Bone Marrow Transplantation, 15, 885 889.
62. Kansu, E., Gooley, T., Flowers, M.E., Anasetti, C., Deeg, H.J., Nash, R.A., Sanders, J.E., Witherspoon, R.P., Appelbaum, F.R., Storb, R. Martin, P.J. (2001) Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial. Blood, 98, 3868 3870.
63. Kiss, T.L., Abdolell, M., Jamal, N., Minden, M.D., Lipton, J.H. Messner, H.A. (2002) Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 20, 2334 2343.
64. Kobashigawa, J.A., Katznelson, S., Laks, H., Johnson, J.A., Yeatman, L., Wang, X.M., Chia, D., Terasaki, P.I., Sabad, A., Cogert, G.A., Trosian, K, Hamilton, MA, Moriguchi, J.D., Kawata, N., Hage, A., Drinkwater, D.C. Stevenson, L.W. (1995) Effect of pravastatin on outcomes after cardiac transplantation. North England Journal of Medicine, 333, 621 627.
65. Koc, S., Leisenring, W., Flowers, M.E., Anasetti, C., Deeg, H.J., Nash, R.A., Sanders, J.E., Witherspoon, R.P., Appelbaum, F.R., Storb, R. Martin, P.J. (2000) Thalidomide for treatment of patients with chronic graft-versus-host disease. Blood, 96, 3995 3996.
66. Koc, S., Leisenring, W., Flowers, M.E., Anasetti, C., Deeg, H.J., Nash, R.A., Sanders, J.E., Witherspoon, R.P., Storb, R., Appelbaum, F.R. Martin, P.J. (2002) Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood, 100, 48 51.
67. Kulkarni, S., Powles, R., Sirohi, B., Treleaven, J., Saso, R., Horton, C., Atra, A., Ortin, M., Rudin, C., Goyal, S., Sankpal, S., Meller, S., Pinkerton, C.R., Mehta, J. Singhal, S. (2003) Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease. Bone Marrow Transplantation, 32, 165 170.
68. Kurtzberg, J., Laughlin, M., Graham, M.L., Smith, C., Olson, J.F., Halperin, E.C., Ciocci, G., Carrier, C., Stevens, C.E. Rubinstein, P. (1996) Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. North England Journal of Medicine, 335, 157 166.
69. Lee, S.J., Wegner, S.A., McGarigle, C.J., Bierer, B.E. Antin, J.H. (1997) Treatment of chronic graft-versus-host disease with clofazimine. Blood, 89, 2298 2302.
70. Lee, S.J., Klein, J.P., Barrett, A.J., Ringden, O., Antin, J.H., Cahn, J.Y., Carabasi, M.H., Gale, R.P., Giralt, S., Hale, G.A., Ilhan, O., McCarthy, P.L., Socie, G., Verdonck, L.F., Weisdorf, D.J. Horowitz, M.M. (2002) Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood, 100, 406 414.
71. Lee, S.J., Vogelsang, G. Flowers, M.E. (2003) Chronic graft-versus-host disease. Biology Blood Marrow Transplantation, 9, 215 233.
72. Lee, S.J., Zahrieh, D., Agura, E., MacMillan, M.L., Maziarz, R.T., McCarthy, P.L., Jr., Ho, V.T., Cutler, C., Alyea, E.P., Antin, J.H. Soiffer, R.J. (2004) Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial. Blood, 104, 1559 1564.
73. Lee, S.J., Kim, H.T., Ho, V.T., Cutler, C., Alyea, E.P., Soiffer, R.J. Antin, J.H. (2006) Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplantation, 38, 305 310.
74. Lopez, F., Parker, P., Nademanee, A., Rodriguez, R., Al-Kadhimi, Z., Bhatia, R., Cohen, S., Falk, P., Fung, H., Kirschbaum, M., Krishnan, A., Kogut, N., Molina, A., Nakamura, R., O'Donnell, M., Popplewell, L., Pullarkat, V., Rosenthal, J., Sahebi, F., Smith, E., Snyder, D., Somlo, G., Spielberger, R., Stein, A., Sweetman, R., Zain, J. Forman, S. (2005) Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biology Blood Marrow Transplantation, 11, 307 313.
75. Marcellus, D.C., Altomonte, V.L., Farmer, E.R., Horn, T.D., Freemer, C.S., Grant, J. Vogelsang, G.B. (1999) Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease. Blood, 93, 66 70.
76. Marmont, A.M., Horowitz, M.M., Gale, R.P., Sobocinski, K., Ash, R.C., van Bekkum, D.W., Champlin, R.E., Dicke, K.A., Goldman, J.M. Good, R.A. (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood, 78, 2120 2130.
77. Martin, P.J., Weisdorf, D., Przepiorka, D., Hirschfeld, S., Farrell, A., Rizzo, J.D., Foley, R., Socie, G., Carter, S., Couriel, D., Schultz, K.R., Flowers, M.E., Filipovich, A.H., Saliba, R., Vogelsang, G.B., Pavletic, S.Z. Lee, S.J. (2006) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biology Blood Marrow Transplantation, 12, 491 505.
78. Maury, S., Mary, J.Y., Rabian, C., Schwarzinger, M., Toubert, A., Scieux, C., Carmagnat, M., Esperou, H., Ribaud, P., Devergie, A., Guardiola, P., Vexiau, P., Charron, D., Gluckman, E. Socie, G. (2001) Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. British Journal of Haematology, 115, 630 641.
79. Mayer, J., Krejci, M., Doubek, M., Pospisil, Z., Brychtova, Y., Tomiska, M. Racil, Z. (2005) Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host disease. Bone Marrow Transplantation, 35, 699 705.
80. Mengarelli, A., Iori, A.P., Romano, A., Cerretti, R., Cerilli, L., De Propris, M.S., Fenu, S., Moleti, M.L., De Felice, L., Girelli, G. Arcese, W. (2003) One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation. Haematologica, 88, 315 323.
81. Messina, C., Locatelli, F., Lanino, E., Uderzo, C., Zacchello, G., Cesaro, S., Pillon, M., Perotti, C., Del Fante, C., Faraci, M., Rivabella, L., Calore, E., De Stefano, P., Zecca, M., Giorgiani, G., Brugiolo, A., Balduzzi, A., Dini, G., Zanesco, L. Dall'Amico, R. (2003) Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. British Journal of Haematology, 122, 118 127.
82. Mielcarek, M., Martin, P.J., Leisenring, W., Flowers, M.E., Maloney, D.G., Sandmaier, B.M., Maris, M.B. Storb, R. (2003) Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood, 102, 756 762.
83. Miklos, D.B., Kim, H.T., Miller, K.H., Guo, L., Zorn, E., Lee, S.J., Hochberg, E.P., Wu, C.J., Alyea, E.P., Cutler, C., Ho, V., Soiffer, R.J., Antin, J.H. Ritz, J. (2005) Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood, 105, 2973 2978.
84. Miura, Y., Thoburn, C.J., Bright, E.C., Phelps, M.L., Shin, T., Matsui, E.C., Matsui, W.H., Arai, S., Fuchs, E.J., Vogelsang, G.B., Jones, R.J. Hess, A.D. (2004) Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood, 104, 2187 2193.
85. Mookerjee, B., Altomonte, V. Vogelsang, G. (1999) Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus. Bone Marrow Transplantation, 24, 517 520.
86. Nash, R.A., Antin, J.H., Karanes, C., Fay, J.W., Avalos, B.R., Yeager, A.M., Przepiorka, D., Davies, S., Petersen, F.B., Bartels, P., Buell, D., Fitzsimmons, W., Anasetti, C., Storb, R. Ratanatharathorn, V. (2000) Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood, 96, 2062 2068.
87. Neumann, F., Graef, T., Tapprich, C., Vaupel, M., Steidl, U., Germing, U., Fenk, R., Hinke, A., Haas, R. Kobbe, G. (2005) Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings. Bone Marrow Transplantation, 35, 1089 1093.
88. Palmas, A., Tefferi, A., Myers, J.L., Scott, J.P., Swensen, S.J., Chen, M.G., Gastineau, D.A., Gertz, M.A., Inwards, D.J., Lacy, M.Q. Litzow, M.R. (1998) Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. British Journal of Haematology, 100, 680 687.
89. Parker, P.M., Chao, N., Nademanee, A., O'Donnell, M.R., Schmidt, G.M., Snyder, D.S., Stein, A.S., Smith, E.P., Molina, A., Stepan, D.E., Kashyap, A., Planas, I., Spielberger, R., Somlo, G., Margolin, K., Zwingenberger, K., Wilsman, K., Negrin, R.S., Long, G.D., Niland, J.C., Blume, K.G. Forman, S.J. (1995) Thalidomide as salvage therapy for chronic graft-versus-host disease. Blood, 86, 3604 3609.
90. Pavletic, S.Z., Carter, S.L., Kernan, N.A., Henslee-Downey, J., Mendizabal, A.M., Papadopoulos, E., Gingrich, R., Casper, J., Yanovich, S. Weisdorf, D. (2005) Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation. Blood, 106, 3308 3313.
91. Pavletic, S.Z., Lee, S.J., Socie, G. Vogelsang, G. (2006a) Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplantation, 38, 645 651.
92. Pavletic, S.Z., Martin, P., Lee, S.J., Mitchell, S., Jacobsohn, D., Cowen, E.W., Turner, M.L., Akpek, G., Gilman, A., McDonald, G., Schubert, M., Berger, A., Bross, P., Chien, J.W., Couriel, D., Dunn, J.P., Fall-Dickson, J., Farrell, A., Flowers, M.E., Greinix, H., Hirschfeld, S., Gerber, L., Kim, S., Knobler, R., Lachenbruch, P.A., Miller, F.W., Mittleman, B., Papadopoulos, E., Parsons, S.K., Przepiorka, D., Robinson, M., Ward, M., Reeve, B., Rider, L.G., Shulman, H., Schultz, K.R., Weisdorf, D. Vogelsang, G.B. (2006b) Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplantation, 12, 252 266.
93. Perez-Simon, J.A., Diez-Campelo, M., Martino, R., Sureda, A., Caballero, D., Canizo, C., Brunet, S., Altes, A., Vazquez, L., Sierra, J. Miguel, J.F. (2003) Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation. Blood, 102, 1108 1113.
94. Randolph, S.S., Gooley, T.A., Warren, E.H., Appelbaum, F.R. Riddell, S.R. (2004) Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood, 103, 347 352.
95. Ratanatharathorn, V., Nash, R.A., Przepiorka, D., Devine, S.M., Klein, J.L., Weisdorf, D., Fay, J.W., Nademanee, A., Antin, J.H., Christiansen, N.P., der Jagt, R., Herzig, R.H., Litzow, M.R., Wolff, S.N., Longo, W.L., Petersen, F.B., Karanes, C., Avalos, B., Storb, R., Buell, D.N., Maher, R.M., Fitzsimmons, W.E. Wingard, J.R. (1998) Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood, 92, 2303 2314.
96. Ratanatharathorn, V., Ayash, L., Lazarus, H.M., Fu, J. Uberti, J.P. (2001) Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplantation, 28, 121 129.
97. Ratanatharathorn, V., Ayash, L., Reynolds, C., Silver, S., Reddy, P., Becker, M., Ferrara, J.L. Uberti, J.P. (2003) Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biology Blood Marrow Transplantation, 9, 505 511.
98. Ratjen, F., Rjabko, O. Kremens, B. (2005) High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplantation, 36, 135 138.
99. Rieger, K., Loddenkemper, C., Maul, J., Fietz, T., Wolff, D., Terpe, H., Steiner, B., Berg, E., Miehlke, S., Bornhauser, M., Schneider, T., Zeitz, M., Stein, H., Thiel, E., Duchmann, R. Uharek, L. (2006) Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD. Blood, 107, 1717 1723.
100. Ringden, O., Labopin, M., Gluckman, E., Reiffers, J., Vernant, J.P., Jouet, J.P., Harrousseau, J.L., Fiere, D., Bacigalupo, A., Frassoni, F. Gorin, N.C. (1996) Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 18, 921 929.
101. Ringden, O., Labopin, M., Gorin, N.C., Le Blanc, K., Rocha, V., Gluckman, E., Reiffers, J., Arcese, W., Vossen, J.M., Jouet, J.P., Cordonnier, C. Frassoni, F. (2004) Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology, 22, 416 423.
102. Ringden, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lonnies, H., Marschall, H.U., Dlugosz, A., Szakos, A., Hassan, Z., Omazic, B., Aschan, J., Barkholt, L. Le Blanc, K. (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation, 81, 1390 1397.
103. Ritchie, D., Seconi, J., Wood, C., Walton, J. Watt, V. (2005) Prospective monitoring of tumor necrosis factor alpha and interferon gamma to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation. Biology Blood Marrow Transplantation, 11, 706 712.
104. Rizzieri, D.A., Koh, L.P., Long, G.D., Gasparetto, C., Sullivan, K.M., Horwitz, M., Chute, J., Smith, C., Gong, J.Z., Lagoo, A., Niedzwiecki, D., Dowell, J.M., Waters-Pick, B., Liu, C., Marshall, D., Vredenburgh, J.J., Gockerman, J., Decastro, C., Moore, J. Chao, N.J. (2007) Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. Journal of Clinical Oncology, 25, 690 697.
105. Ross, M., Schmidt, G.M., Niland, J.C., Amylon, M.D., Dagis, A.C., Long, G.D., Nademanee, A.P., Negrin, R.S., O'Donnell, M.R., Parker, P.M., Smith, E.P., Snyder, D.S., Stein, A.S., Wong, R.M., Forman, S.J., Blume, K.G. Chao, N.J. (1999) Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival. Biology Blood Marrow Transplantation, 5, 285 291.
106. Ruutu, T., Volin, L., Parkkali, T., Juvonen, E. Elonen, E. (2000) Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study. Blood, 96, 2391 2398.
107. Ruutu, T., Eriksson, B., Remes, K., Juvonen, E., Volin, L., Remberger, M., Parkkali, T., Hagglund, H. Ringden, O. (2002) Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood, 100, 1977 1983.
108. Sakaida, E., Nakaseko, C., Harima, A., Yokota, A., Cho, R., Saito, Y. Nishimura, M. (2003) Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood, 102, 4236 4242.
109. Sakoda, Y., Hashimoto, D., Asakura, S., Takeuchi, K., Harada, M., Tanimoto, M. Teshima, T. (2007) Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. Blood, 109, 1756 1764.
110. Schultz, K.R., Miklos, D.B., Fowler, D., Cooke, K., Shizuru, J., Zorn, E., Holler, E., Ferrara, J., Shulman, H., Lee, S.J., Martin, P., Filipovich, A.H., Flowers, M.E., Weisdorf, D., Couriel, D., Lachenbruch, P.A., Mittleman, B., Vogelsang, G.B. Pavletic, S.Z. (2006) Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. Biomarker Working Group Report. Biology Blood Marrow Transplantation, 12, 126 137.
111. Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.S., Storb, R. Thomas, E.D. (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine, 69, 204 217.
112. Shulman, H.M., Kleiner, D., Lee, S.J., Morton, T., Pavletic, S.Z., Farmer, E., Moresi, J.M., Greenson, J., Janin, A., Martin, P.J., McDonald, G., Flowers, M.E., Turner, M., Atkinson, J., Lefkowitch, J., Washington, M.K., Prieto, V.G., Kim, S.K., Argenyi, Z., Diwan, A.H., Rashid, A., Hiatt, K., Couriel, D., Schultz, K., Hymes, S. Vogelsang, G.B. (2006) Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biology Blood Marrow Transplantation, 12, 31 47.
113. Socie, G., Devergie, A., Cosset, J.M., Pierga, J.Y., Esperou, H., Girinski, T. Gluckman, E. (1990) Low-dose (one gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease. Transplantation, 49, 657 658.
114. Socie, G., Stone, J.V., Wingard, J.R., Weisdorf, D., Henslee-Downey, P.J., Bredeson, C., Cahn, J.Y., Passweg, J.R., Rowlings, P.A., Schouten, H.C., Kolb, H.J. Klein, J.P. (1999) Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. North England Journal of Medicine, 341, 14 21.
115. Sokos, D.R., Berger, M. Lazarus, H.M. (2002) Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation. Biology Blood Marrow Transplantation, 8, 117 130.
116. Stewart, B.L., Storer, B., Storek, J., Deeg, H.J., Storb, R., Hansen, J.A., Appelbaum, F.R., Carpenter, P.A., Sanders, J.E., Kiem, H.P., Nash, R.A., Petersdorf, E.W., Moravec, C., Morton, A.J., Anasetti, C., Flowers, M.E. Martin, P.J. (2004) Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood, 104, 3501 3506.
117. Storb, R., Deeg, H.J., Farewell, V., Doney, K., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R. Hansen, J. (1986) Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood, 68, 119 125.
118. Storb, R., Deeg, H.J., Pepe, M., Appelbaum, F., Anasetti, C., Beatty, P., Bensinger, W., Berenson, R., Buckner, C.D. Clift, R. (1989) Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood, 73, 1729 1734.
119. Storb, R., Pepe, M., Anasetti, C., Appelbaum, F.R., Beatty, P., Doney, K., Martin, P., Stewart, P., Sullivan, K.M., Witherspoon, R., Bensinger, W, Buckner, C.D., Clift, R., Hansen, J., Longton, G., Loughran, T., Petersen, F.B., Singer, J., Sanders, J. Thomas, E.D. (1990) What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? Blood, 76, 1037 1045.
120. Sullivan, K.M., Witherspoon, R.P., Storb, R., Deeg, H.J., Dahlberg, S., Sanders, J.E., Appelbaum, F.R., Doney, K.C., Weiden, P. Anasetti, C. (1988a) Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-vs-host disease. Blood, 72, 555 561.
121. Sullivan, K.M., Witherspoon, R.P., Storb, R., Weiden, P., Flournoy, N., Dahlberg, S., Deeg, H.J., Sanders, J.E., Doney, K.C. Appelbaum, F.R. (1988b) Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-vs-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood, 72, 546 554.
122. Sullivan, K.M., Kopecky, K.J., Jocom, J., Fisher, L., Buckner, C.D., Meyers, J.D., Counts, G.W., Bowden, R.A., Peterson, F.B., Witherspoon, R.P., Budinger, M.D., Schwartz, R.S., Appelbaum, F.R., Clift, R.A., Hansen, J.A., Sanders, J.E., Thomas, E.D. Storb, R. (1990) Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. North England Journal of Medicine, 323, 705 712.
123. Sullivan, K.M., Storek, J., Kopecky, K.J., Jocom, J., Longton, G., Flowers, M., Siadak, M., Nims, J., Witherspoon, R.P., Anasetti, C., Appelbaum, F.R., Bowden, R.A., Buckner, C.D., Crawford, S.W., Deeg, H.J., Hansen, J.A., McDonald, G.B., Sanders, J.E. Storb, R. (1996) A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. Biology Blood Marrow Transplantation, 2, 44 53.
124. Syrjala, K.L., Langer, S.L., Abrams, J.R., Storer, B., Sanders, J.E., Flowers, M.E. Martin, P.J. (2004) Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. Jama, 291, 2335 2343.
125. Teachey, D.T., Bickert, B. Bunin, N. (2006) Daclizumab for children with corticosteroid refractory graft-versus-host disease. Bone Marrow Transplantation, 37, 95 99.
126. Vogelsang, G.B., Farmer, E.R., Hess, A.D., Altamonte, V., Beschorner, W.E., Jabs, D.A., Corio, R.L., Levin, L.S., Colvin, O.M., Wingard, J.R. Santos, G.W. (1992) Thalidomide for the treatment of chronic graft-versus-host disease. North England Journal of Medicine, 326, 1055 1058.
127. Vogelsang, G.B., Wolff, D., Altomonte, V., Farmer, E., Morison, W.L., Corio, R. Horn, T. (1996) Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplantation, 17, 1061 1067.
128. Wagner, J.E., Thompson, J.S., Carter, S.L. Kernan, N.A. (2005) Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial. Lancet, 366, 733 741.
129. Willenbacher, W., Basara, N., Blau, I.W., Fauser, A.A. Kiehl, M.G. (2001) Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab. British Journal of Haematology, 112, 820 823.
130. Winston, D.J., Antin, J.H., Wolff, S.N., Bierer, B.E., Small, T., Miller, K.B., Linker, C., Kaizer, H., Lazarus, H.M., Petersen, F.B., Cowan, M.J., Ho, W.G., Wingard, J.R., Schiller, G.J., Territo, M.C., Jiao, J., Petrarca, M.A. Tonetta, S.A. (2001) A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 28, 187 196.
131. Zaucha, J.M., Gooley, T., Bensinger, W.I., Heimfeld, S., Chauncey, T.R., Zaucha, R., Martin, P.J., Flowers, M.E., Storek, J., Georges, G., Storb, R. Torok-Storb, B. (2001) CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood, 98, 3221 3227.
132. Zhang, C., Todorov, I., Zhang, Z., Liu, Y., Kandeel, F., Forman, S., Strober, S. Zeng, D. (2006) Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood, 107, 2993 3001.
133. Zorn, E., Kim, H.T., Lee, S.J., Floyd, B.H., Litsa, D., Arumugarajah, S., Bellucci, R., Alyea, E.P., Antin, J.H., Soiffer, R.J. Ritz, J. (2005) Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood, 106, 2903 2911.